Market Tracker

08/21 6:05pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

During the Trading Day
1.41 -0.01 / -0.70%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.41 -0.0003 / -0.02%
 
Volume: 38.6K

Today’s Trading

Previous close1.42
Today’s open1.43
Day’s range1.40 - 1.43
Volume690,961
Average volume (3 months)1,797,929
Market cap$373.3M
Dividend yield--
Data as of 3:59pm ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+11.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.18-2.84%
SUPNSupernus Pharmaceuti...-0.26-2.94%
PETXAratana Therapeutics...-0.21-1.71%
PGNXProgenics Pharmaceut...-0.06-1.16%
Data as of 3:59pm ET, 08/21/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts